Deep Medicine Acquisition Corp.
NASDAQ:DMAQ
2.96 (USD) • At close January 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | |
---|---|---|
Revenue
| 0 | 0 |
Cost of Revenue
| 0.06 | 0.06 |
Gross Profit
| -0.06 | -0.06 |
Gross Profit Ratio
| 0 | 0 |
Reseach & Development Expenses
| 0 | 0 |
General & Administrative Expenses
| 1.907 | 0.41 |
Selling & Marketing Expenses
| 0 | 0 |
SG&A
| 1.907 | 0.41 |
Other Expenses
| 0.2 | 0.06 |
Operating Expenses
| 2.107 | 0.41 |
Operating Income
| -0.343 | -0.462 |
Operating Income Ratio
| 0 | 0 |
Total Other Income Expenses Net
| 1.884 | 0.048 |
Income Before Tax
| -0.343 | -0.414 |
Income Before Tax Ratio
| 0 | 0 |
Income Tax Expense
| 0.058 | -0.056 |
Net Income
| -0.4 | -0.358 |
Net Income Ratio
| 0 | 0 |
EPS
| -0.17 | -0.041 |
EPS Diluted
| -0.17 | -0.041 |
EBITDA
| -3.992 | -0.406 |
EBITDA Ratio
| 0 | 0 |